JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stover, E. P.
Right arrow Articles by McKenna, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stover, E. P.
Right arrow Articles by McKenna, T. R.
Anesth Analg 2000;90:509-516
© 2000 International Anesthesia Research Society


CARDIOVASCULAR ANESTHESIA

Platelet-Rich Plasma Sequestration, with Therapeutic Platelet Yields, Reduces Allogeneic Transfusion in Complex Cardiac Surgery

E. Price Stover, MD, Lawrence C. Siegel, MD, Patricia A. Hood, CCP, Geraldine E. O’Riordan, RN, and Timothy R. McKenna, BS

Department of Anesthesia, Stanford University School of Medicine, Stanford, California

Address correspondence and reprint requests to E. Price Stover, MD, Department of Anesthesia, Room H3580, Stanford University School of Medicine, Stanford, CA 94305.

Platelet dysfunction is the most common cause of nonsurgical bleeding after cardiopulmonary bypass (CPB). We hypothesized that reinfusion of a therapeutic quantity of platelets sequestered before CPB would decrease the need for allogeneic platelet transfusion, as well as decrease bleeding and total allogeneic transfusion, in cardiac surgery patients at moderately high risk for bleeding. Fifty-five patients undergoing either reoperative coronary artery bypass (CABG) or combined CABG and valve replacement were randomized to control or platelet-rich plasma sequestration (pheresis) groups. All patients received intraoperative {epsilon}-aminocaproic acid infusions. There was no significant difference between groups with respect to preoperative characteristics, duration of CPB, or target postoperative hematocrit. Mean platelet yields were 6.2 ± 2.1 units (3.1 x 1011 platelets). Mean pheresis time was 44 min. Allogeneic platelets (range = 6–12 units) were transfused to 28% of control patients, compared with 0% of pheresis patients (P < 0.01). Allogeneic packed red blood cells were transfused to 45% of control patients (1.2 units per patient) versus 31% of pheresis patients (0.7 unit per patient) (P = 0.35). Total allogeneic units transfused were significantly reduced in the pheresis group (P < 0.02). Mediastinal chest tube drainage was not significantly decreased in the pheresis group. In this prospective, randomized study, therapeutic platelet yields were obtained before CPB. In contrast with recent studies with low platelet yields, these data support the conclusion that platelet-rich plasma sequestration is effective in reducing allogeneic platelet transfusions and total allogeneic units transfused in cardiac surgery patients at moderately high risk for post-CPB coagulopathy and bleeding.

Implications: Transfusion of allogeneic blood products, including platelets, is common during complex cardiac surgical procedures. In the present prospective, randomized study, a significant reduction in allogeneic platelet transfusion and total allogeneic units transfused was observed after the reinfusion of a therapeutic quantity of autologous platelets sequestered before cardiopulmonary bypass.




This article has been cited by other articles:


Home page
ICVTSHome page
B. Koul, F. Al-Rashidi, M. Bhat, and L. Pierre
ICVTS on-line discussion A1 Reply to Kan
Interactive CardioVascular and Thoracic Surgery, October 1, 2007; 6(5): 622 - 622.
[Full Text] [PDF]


Home page
ICVTSHome page
F. Al-Rashidi, M. Bhat, L. Pierre, and B. Koul
Acute plateletpheresis and aprotinin reduces the need for blood transfusion following Ross operation
Interactive CardioVascular and Thoracic Surgery, October 1, 2007; 6(5): 618 - 622.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. S. Donahue
Factor V Leiden and Perioperative Risk
Anesth. Analg., June 1, 2004; 98(6): 1623 - 1634.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
S. Samson and L. Shore-Lesserson
Platelet Function and Cardiopulmonary Bypass
Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2001; 5(4): 273 - 281.
[Abstract] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
L. Shore-Lesserson
Monitoring the Hematologic Complications of Cardiopulmonary Bypass
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 207 - 216.
[Abstract] [PDF]


Home page
Anesth. Analg.Home page
P. Wajon, J. Gibson, R. Calcroft, C. Hughes, and B. Thrift
Intraoperative Plateletpheresis and Autologous Platelet Gel Do Not Reduce Chest Tube Drainage or Allogeneic Blood Transfusion After Reoperative Coronary Artery Bypass Graft
Anesth. Analg., September 1, 2001; 93(3): 536 - 542.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2000 by the International Anesthesia Research Society.